Coronavirus disease 2019 (COVID-19) is an emerging, fast-spreading, highly mortal and worldwide infectious disease. The pulmonary system was defined as the main target of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but the mortality concept of this disease presented with more severe and systemic disease. The present study investigated the relationship between the patient characteristics at the initial hospital administration and fatality in COVID-19 patients.
In this retrospective and comparative cohort study, all the 767 hospitalized COVID-19 patients, treated between March 18 and May 15, 2020 in the Covid Clinics of Gulhane Training and Research Hospital in Ankara, Turkey were evaluated.
The fatality rate was significantly increased in patients with any comorbid disease except asthma. The initial laboratory test results indicated highly significant differences according to the patient’s outcome. A multifactor logistic regression analysis was performed to calculate the adjusted odds ratios for predicting patient outcomes. Being older than 60 years increased the death risk with an adjusted OR of 7.2 (95% CI 2.23 – 23.51; p=0.001). The presence of a cancer and the extended duration of intensive care unit treatment were other significant risk factors for non-survival. Azithromycin treatment was determined as significantly reduced the death ratio in these patients (p=0.002).
It was revealed that being older than 60, presence of a cancer, and extended duration of ICU treatment were the major risk factors for predicting fatality rate in hospitalized COVID-19 patients.

This article is protected by copyright. All rights reserved.

Author